TY  - GEN
AU  - Arwood,M J
AU  - Deng,J
AU  - Drozda,K
AU  - Pugach,O
AU  - Nutescu,E A
AU  - Schmidt,S
AU  - Duarte,J D
AU  - Cavallari,L H
TI  - Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach
SN  - 1532-6535
PY  - 2017///0425
KW  - Algorithms
KW  - Alleles
KW  - Anticoagulants
KW  - administration & dosage
KW  - Cytochrome P-450 CYP2C9
KW  - genetics
KW  - Dose-Response Relationship, Drug
KW  - Endpoint Determination
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Pharmacogenetics
KW  - Vitamin K Epoxide Reductases
KW  - Warfarin
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/cpt.558
ER  -